Fig. 1From: EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrationsIHC analysis of EHD1 expression and correlation between EHD1 and survival in NSCLC tissues. EHD1-negative (a:x100; bx400:) and EHD1-positive (c:x100;d:x400) tumour samples are shown. Tissue sections were stained with EHD1-specific antibodies, and an immunohistochemical analysis was conducted as described in the Materials and Methods. e: OS in NSCLC patients receiving adjuvant chemotherapy. Patients receiving post-operational adjuvant chemotherapy with positive EHD1 expression exhibited reduced OS (Pā=ā0.01)Back to article page